Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $159.88M in the quarter ending March 31, 2026, with 43.28% growth. This brings the company's revenue in the last twelve months to $569.61M, up 50.19% year-over-year. In the year 2025, Mirum Pharmaceuticals had annual revenue of $521.31M with 54.74% growth.

• Revenue (ttm): $569.61M
• Revenue Growth: +50.19%
• P/S Ratio: 11.24
• Revenue / Employee: $1,531,207
• Employees: 372
• Market Cap: 6.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	521.31M	184.42M	54.74%
Dec 31, 2024	336.89M	150.51M	80.76%
Dec 31, 2023	186.37M	109.31M	141.85%
Dec 31, 2022	77.06M	57.92M	302.66%
Dec 31, 2021	19.14M	-	-

Data Source: S&P Global Market Intelligence Last updated: May 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error